Imatinib (STI571): Mechanistic Precision and Translationa...
2025-10-21
This thought-leadership article explores the mechanistic foundations and translational impact of Imatinib (STI571), a selective protein-tyrosine kinase inhibitor. Designed for translational researchers and scientific leaders, the narrative integrates current evidence, competitive context, and practical guidance, while highlighting new frontiers in kinase signaling, tumor microenvironment research, and the evolving implications for cancer biology.